Veeva Systems Hosts Biopharma Summit in Europe
Veeva Systems will host the Veeva R&D and Quality Summit in Madrid, Spain, on June 4-5, 2025. The event will feature keynotes from leaders in the biopharma industry, including Bayer, Lonza, MSD, Novo Nordisk, Recipharm, and Teva. These sessions will explore how connected platforms and AI can enhance the development and manufacturing of new medicines, announced in a press release.
The summit will bring together over 1,400 industry professionals for more than 100 sessions, focusing on advancements in clinical, regulatory, safety, and quality sectors. A major highlight will be the introduction of Veeva AI, an initiative to integrate AI into the Veeva Vault Platform to automate critical functions and improve productivity.
Keynote speakers will discuss various topics, such as Bayer's approach to streamlining clinical infrastructure, Lonza's reshaping of quality management, and MSD's innovations in pharmacovigilance. Novo Nordisk will share insights on accelerating clinical trials, while Teva will highlight its data-driven strategies for navigating regulatory changes.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Servier Adopts Veeva OpenData Across More Than 80 Countries
Amgen Selects Veeva Vault CRM for Global Deployment
Sequential Plans London Conference on AI Ingredient Discovery
AbbVie Partners With Valkai on AI Tools for Clinical Development
Veeva Introduces AI Agent for Clinical Study Configuration
Daily AI Brief: the AI news that matters, in your inbox.